Symptom Management After Breast Cancer Surgery

• Status: Completed
• Trial end date: 2007-12-01
• Target enrollment: 0
• Participant gender: Female

Summary

This trial is part of a larger, longitudinal study of symptoms that occur in the breast surgical scar area and/or ipsilateral arm following breast cancer surgery. Women who develop pain in the breast scar area or ipsilateral arm will be randomized to a placebo patch or a lidocaine patch that they will wear on a daily basis for 12 weeks. We hypothesize that women who wear the lidocaine patch will report a decrease in pain and decreased interference with function compared to women who wear the placebo patch.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University of California, San Francisco
• Treatments: Lidocaine

Criteria

Inclusion Criteria:

• Adult women >18 years who develop neuropathic pain in the breast scar area and/or ipsilateral arm following breast cancer surgery

• Has a healed incision(s)

• Has no recurrent disease in the painful area

• Is able to read, write and understand English

Exclusion Criteria:

• Presence of another type of pain that is more severe than the neuropathic pain

• Use of an opioid analgesic of greater than 60 mg codeine/day

• Is actively trying to become pregnant

• Has a medical contraindication to the use of lidocaine

• Has an allergy to lidocaine

• Is taking a coanalgesic for neuropathic pain.